Tech Company Financing Transactions
ParinGenix Funding Round
On 9/30/2006, ParinGenix received $20.4 million in funding from Aurora Funds, Domain Associates and RCT BioVentures.
Transaction Overview
Company Name
Announced On
9/30/2006
Transaction Type
Venture Equity
Amount
$20,400,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11540 N Community House Rd. 150
Charlotte, NC 28277
USA
Charlotte, NC 28277
USA
Phone
Website
Email Address
Not Recorded
Overview
Operates a virtual company focusing early stage drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Leire
Browse more venture capital transactions:
Prev: 9/30/2006: HyPerformix venture capital transaction
Next: 9/30/2006: Oce Business Services venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs